Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 6/20 | 0.39 |
| ▸ | CTSD | P07339 | 1/20 | 0.39 |
| ▸ | MME | P08473 | 1/20 | 0.36 |
| ▸ | ACE | P12821 | 1/20 | 0.36 |
| ▸ | CPA1 | P15085 | 1/20 | 0.36 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.36 |
| ▸ | CTSC | P53634 | 1/20 | 0.35 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.35 |
| ▸ | DPP4 | P27487 | 1/20 | 0.35 |
| ▸ | FAP | Q12884 | 1/20 | 0.35 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.35 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.35 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29543266 | 0.97 | BACE1 (0.40) | BACE1CTSDMMEACECPA1 | |
| SCHEMBL30440990 | 0.92 | BACE1 (0.38) | BACE1CTSDMMECTSCSLC7A5 | |
| SCHEMBL31106895 | 0.92 | MME (0.37) | BACE1CTSDMMEACECPA1 | |
| SCHEMBL30567436 | 0.90 | BACE1 (0.38) | BACE1MMECTSCSLC7A5DPP4 | |
| SCHEMBL31106879 | 0.90 | MME (0.42) | MMEACECPA1ACE2CTSC | |
| SCHEMBL22542531 | 0.90 | MME (0.42) | MMEACECPA1ACE2CTSC | |
| SCHEMBL31106880 | 0.90 | MME (0.42) | MMEACECPA1ACE2CTSC | |
| SCHEMBL29839285 | 0.88 | MME (0.39) | BACE1CTSDMMEACECPA1 | |
| SCHEMBL8278141 | 0.86 | DPP4 (0.47) | BACE1CTSDMMEACECPA1 | |
| SCHEMBL30051084 | 0.86 | DPP4 (0.47) | BACE1CTSDMMEACECPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE50178-E1 | Humanised antibodies | UCB Biopharma SRL (BE) | 2024-10-22 | — | — | US | disclosed |